Valiant Organics schedules 21st AGM for Sep 29 via VC/OAVM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • 21st AGM scheduled for September 29, 2026, at 11:30 am
  • Meeting conducted via Video Conferencing or OAVM
  • Notice compliant with SEBI LODR Regulations 30 and 47
  • Annual Report for FY26 available on exchange websites
powered bylight_fuzz_icon
49876732

*this image is generated using AI for illustrative purposes only.

Valiant Organics has scheduled its 21st Annual General Meeting for Tuesday, September 29, 2026. The meeting will commence at 11:30 am and will be conducted through Video Conferencing or Other Audio Visual Means.

The company issued the notice in compliance with Regulation 30 and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting aims to transact ordinary and special business as outlined in the notice.

Meeting Details

Shareholders can access the Notice of AGM and the Annual Report for FY26 through multiple channels. Electronic copies are being sent to members with registered email addresses. Physical communications containing links are being dispatched to those without registered emails.

The documents are also available on:

Compliance and Governance

Kaustubh Bhalchandra Kulkarni, Company Secretary of Valiant Organics Limited, signed the disclosure. The company published advertisements regarding the AGM in Financial Express and Mumbai Lakshdeep newspapers to ensure broad shareholder awareness.

Historical Stock Returns for Valiant Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+3.01%+12.90%+31.15%-10.67%-76.72%

What specific special business resolutions are shareholders expected to vote on during the AGM?

How might the FY26 financial performance disclosed in the Annual Report influence Valiant Organics' stock valuation in Q3 2026?

Are there any anticipated changes to the board of directors or executive compensation packages to be approved at this meeting?

Valiant Organics Q1FY27 Results: Net profit up 257% YoY to ₹293 crore

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Consolidated net profit surged 257% YoY to ₹293 crore in Q1FY27
  • Operational revenue grew 13.3% to ₹2,315 crore, hitting a six-quarter high
  • EBITDA margin expanded by 584 bps to 17.97%, driven by lower raw material costs
  • Share of profit from associates jumped to ₹72 crore from ₹6 crore year-ago
  • Hydrogenation segment contributed 54% of total revenue at ₹1,272 crore
powered bylight_fuzz_icon
48850785

*this image is generated using AI for illustrative purposes only.

Valiant Organics reported a consolidated net profit of ₹293 crore for the quarter ended June 30, 2026, marking a 257% increase from ₹82 crore in the same period last year. Operational revenue rose 13.3% year-on-year to ₹2,315 crore, reflecting improved demand across its specialty chemicals portfolio.

The company’s earnings presentation, filed with stock exchanges on August 21, 2026, highlights significant margin expansion. Consolidated EBITDA grew 67.7% to ₹416 crore, pushing the operating margin to 17.97%, the highest in six quarters. This improvement was supported by a reduction in raw material costs, which fell to 57% of sales from 61% previously.

Financial Performance

The bottom-line improvement was broad-based, driven by operational efficiency and lower finance costs. Key financial metrics for Q1FY27 are outlined below:

Metric Q1FY27 Q1FY26 Change
Revenue ₹2,315 crore ₹2,044 crore +13.3%
EBITDA ₹416 crore ₹248 crore +67.7%
EBITDA Margin 17.97% 12.13% +584 bps
Net Profit ₹293 crore ₹82 crore +257%

Standalone net profit also surged, rising 187% to ₹218 crore from ₹76 crore in Q1FY26. Standalone revenue remained flat at ₹2,315 crore, indicating that the parent entity accounts for the majority of the group's operational turnover.

What the Numbers Show

A significant portion of the profit growth stems from non-operational sources. The share of profit from associates contributed ₹72 crore to the consolidated PBT, compared to just ₹6 crore in Q1FY26. While operational EBITDA drove margin expansion, this surge in associate profits indicates a high dependency on joint ventures or equity investments for the current quarter’s bottom-line beat. Additionally, gross profit margins improved to 43% from 39%, aided by a ~410 basis point reduction in raw material consumption.

Segmental Highlights

Hydrogenation remains the largest revenue contributor, accounting for 54% of total sales in Q1FY27. Revenue from this segment grew to ₹1,272 crore from ₹1,082 crore year-ago. Chlorination revenue also expanded to ₹451 crore, up from ₹394 crore. Ammonolysis revenue remained stable at ₹478 crore.

Volume data reveals mixed trends. Chlorination sales volumes declined to 2,623 MT from 3,301 MT, suggesting price-led revenue growth. Conversely, hydrogenation volumes saw a slight dip to 4,916 MT from 5,491 MT in Q4FY26 but remain robust compared to prior periods.

Balance Sheet and Outlook

The company maintains a conservative leverage profile. As of FY26, the net debt-to-equity ratio stood at 0.33x, unchanged from FY25. Total borrowings were ₹2,527 crore (consolidated), comprising ₹526 crore in non-current liabilities and ₹2,001 crore in current liabilities. Cash and cash equivalents were minimal at ₹18 crore.

Management noted that employee and other expenses increased only 4.6% despite 14% revenue growth, reflecting improved operating efficiency. Finance costs declined 15% to ₹51 crore. The company operates six manufacturing units across five locations with a total capacity of 70,000 tonnes per annum.

Historical Stock Returns for Valiant Organics

1 Day5 Days1 Month6 Months1 Year5 Years
+4.99%+3.01%+12.90%+31.15%-10.67%-76.72%

How sustainable is the 17.97% operating margin given the reliance on lower raw material costs, and what hedging strategies are in place for potential commodity price volatility?

What specific operational or market factors contributed to the decline in chlorination sales volumes despite revenue growth, and does this indicate a shift toward higher-margin niche products?

To what extent will the significant surge in profit from associates recur in subsequent quarters, and what are the strategic plans for these joint ventures to ensure consistent bottom-line contributions?

More News on Valiant Organics

1 Year Returns:-10.67%